Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013
-
Upload
claudia-hendrix -
Category
Documents
-
view
102 -
download
4
description
Transcript of Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013
![Page 1: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/1.jpg)
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013
![Page 2: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/2.jpg)
Location of Centers Participatingin the CIBMTR 2013
![Page 3: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/3.jpg)
Transplant Activity in the US
![Page 4: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/4.jpg)
Allogeneic Stem Cell Sources by Recipient Age
![Page 5: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/5.jpg)
Autologous Stem Cell Sources by Recipient Age
![Page 6: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/6.jpg)
Trends in Transplantsby Type and Recipient Age*
![Page 7: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/7.jpg)
Trends in Transplants by Transplant Type and Recipient Age*
![Page 8: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/8.jpg)
Indications for Hematopoietic Stem Cell Transplants in the US, 2011
![Page 9: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/9.jpg)
Indications for Hematopoietic Stem Cell Transplants for Age ≤ 20 years, in the US, 2011
![Page 10: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/10.jpg)
Allogeneic Transplants for Age ≤ 20 years, Registered with the CIBMTR
![Page 11: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/11.jpg)
Allogeneic Transplants for Age > 20 years, Registered with the CIBMTR
![Page 12: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/12.jpg)
Unrelated Donor Stem Cell Sourcesby Recipient Age
![Page 13: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/13.jpg)
Unrelated Cord Blood Transplants by AgeRegistered with the CIBMTR
![Page 14: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/14.jpg)
One-year Survival by Year of Transplant, Donor and Age, Worldwide
![Page 15: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/15.jpg)
100-day Mortality after Autologous Transplants, 2010-2011
![Page 16: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/16.jpg)
100-day Mortality after HLA-identical Sibling Transplants, 2010-2011
![Page 17: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/17.jpg)
100-day Mortality after Unrelated Donor Transplants, 2010-2011
![Page 18: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/18.jpg)
Causes of Death after Autologous Transplants done in 2010-2011
![Page 19: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/19.jpg)
Causes of Death after HLA-identical Sibling Transplants done in 2010-2011
![Page 20: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/20.jpg)
Causes of Death after Unrelated Donor Transplants done in 2010-2011
![Page 21: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/21.jpg)
Allogeneic Transplants Registered with the CIBMTR
![Page 22: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/22.jpg)
Allogeneic Transplants after Reduced Intensity Conditioning, by Donor Type, Registered with CIBMTR
![Page 23: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/23.jpg)
Proportion of Allogeneic Transplants with Reduced Intensity Conditioning for Different Indications
![Page 24: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/24.jpg)
Survival after HLA-identical Sibling Donor Transplants for AML, 2001-2011
![Page 25: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/25.jpg)
Survival after Unrelated Donor Transplants for AML, 2001-2011
![Page 26: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/26.jpg)
Survival after HLA-identical Sibling Donor Transplants for AML, Age < 20 years, 2001-2011
![Page 27: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/27.jpg)
Survival after Allogeneic Transplants for MDS, 2001-2011
![Page 28: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/28.jpg)
Survival after HLA-identical Sibling Donor Transplants for ALL, Age < 20 years, 2001-2011
![Page 29: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/29.jpg)
Survival after Unrelated Donor Transplants for ALL, Age < 20 years, 2001-2011
![Page 30: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/30.jpg)
Survival after HLA-identical Sibling Donor Transplants for ALL, Age ≥ 20 years, 2001-2011
![Page 31: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/31.jpg)
Survival after Unrelated Donor Transplants for ALL, Age ≥ 20 Years, 2001-2011
![Page 32: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/32.jpg)
Survival after HLA-identical Sibling Donor Transplants for CML, 2001-2011
![Page 33: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/33.jpg)
Survival after HLA-matched Sibling Donor Hematopoietic Cell Transplants for CLL,
2001-2011
![Page 34: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/34.jpg)
Survival after Allogeneic Transplants for SAA, 2001-2011
![Page 35: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/35.jpg)
Survival after Autologous Transplants for Hodgkin Lymphoma, 2001-2011
![Page 36: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/36.jpg)
Survival after Allogeneic Transplants for Hodgkin Lymphoma, 2001-2011
![Page 37: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/37.jpg)
Survival after Autologous Transplants for Follicular Lymphoma, 2001-2011
![Page 38: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/38.jpg)
Survival after Allogeneic and HLA-identical Sibling Transplants for Follicular Lymphoma, 2001-2011
![Page 39: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/39.jpg)
Survival after Autologous Transplants for Diffuse Large B-Cell Lymphoma, 2001-2010
![Page 40: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/40.jpg)
Survival after HLA-identical Sibling Transplants for Diffuse Large B-Cell Lymphoma, 2001-2011
![Page 41: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/41.jpg)
Survival after Transplants for Mantle Cell Lymphoma, 2001-2011
![Page 42: Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2013](https://reader035.fdocuments.net/reader035/viewer/2022062408/568131d1550346895d9839f4/html5/thumbnails/42.jpg)
Survival after Transplants for Multiple Myeloma, 2001-2011